The effect of mitomycin on extracellular matrix proteins in a rat wound model

Laryngoscope

Volumn 113, Issue 2, 2003, Pages 237-242

  Gray, Steven D ^a   Tritle, Nathan ^a   Li, Wenhua ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Extracellular matrix; Mitomycin; Scarring; Wound healing

Indexed keywords

ELASTASE; HYALURONIDASE; MESSENGER RNA; MITOMYCIN C; POLYVINYL ALCOHOL SPONGE; PROCOLLAGEN; SCLEROPROTEIN; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FIBROBLAST; GENE EXPRESSION REGULATION; GENE REPRESSION; IMPLANTATION; INJECTION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RAT; SKIN INCISION; SURGICAL WOUND; WOUND DEHISCENCE; WOUND HEALING IMPAIRMENT;

ADMINISTRATION, TOPICAL; ANIMALS; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; FIBROSIS; GENE EXPRESSION; INJECTIONS; MALE; MITOMYCIN; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; WOUND HEALING;

EID: 0037312912     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200302000-00008     Document Type: Article

References (35)

1. Ihnat MA, Lariviere JP, Warren AJ, et al. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents. Clin Cancer Res 1997;3:1339-1346.
2. Cheung JC, Wright MM, Murali S, Pederson JE. Intermediate-term outcome of variable dose mitomycin C filtering surgery. Ophthalmology 1997;104:143-149.
3. Hu D, Sires BS, Tong DC, Royack GA, Oda D. Effect of brief exposure to mitomycin C on cultured human nasal mucosa fibroblasts. Ophthalmic Plast Reconstr Surg 2000;16:119-125.
4. Kao SC, Liao CL, Tseng JH, Chen MS, Hou PK. Dacryocystorhinostomy with intraoperative mitomycin C. Ophthalmology 1997;104:86-91.
5. Woo KI, Moon SH, Kim YD. Transcanalicular laser-assisted revision of failed dacryocystorhinostomy. Ophthalmic Surg Lasers 1998;29:451-455.
6. Yeatts RP, Neves RB. Use of mitomycin C in repeat dacryocystorhinostomy. Ophthalmic Plast Reconstr Surg 1999;15:19-22.
7. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology 1988;95:813-821.
8. Chen CW, Huang HT, Bair JS, Lee CC. Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. J Ocul Pharmacol 1990;6:175-182.
9. Tsai CC, Kau HC, Kao SC, Hsu WM, Liu JH. Efficacy of probing the nasolacrimal duct with adjunctive mitomycin-C for epiphora in adults. Ophthalmology 2002;109:172-174.
10. Ward RF, April MM. Mitomycin-C in the treatment of tracheal cicatrix after tracheal reconstruction. Int J Pediatr Otorhinolaryngol 1998;44:221-226.
11. Ingrams DR, Volk MS, Biesman BS, Pankratov MM, Shapshay SM. Sinus surgery: does mitomycin C reduce stenosis? Laryngoscope 1998;108:883-886.
12. Spector JE, Werkhaven JA, Spector NC, et al. Preservation of function and histologic appearance in the injured glottis with topical mitomycin-C. Laryngoscope 1999;109:1125-1129.
13. Eliashar R, Eliachar I, Esclamado R, Gramlich T, Strome M. Can topical mitomycin prevent laryngotracheal stenosis? Laryngoscope 1999;109:1594-1600.
14. Estrem SA, Batra PS. Preventing myringotomy closure with topical mitomycin C in rats. Otolaryngol Head Neck Surg 1999;120:794-798.
15. Correa AJ, Reinisch L, Sanders DL, et al. Inhibition of subglottic stenosis with mitomycin-C in the canine model. Ann Otol Rhinol Laryngol 1999;108:1053-1060.
16. Rahbar R, Valdez TA, Shapshay SM. Preliminary results of intraoperative mitomycin-C in the treatment and prevention of glottic and subglottic stenosis. J Voice 2000;14:282-286.
17. Holland BW, McGuirt WF Jr. Surgical management of choanal atresia: improved outcome using mitomycin. Arch Otolaryngol Head Neck Surg 2001;127:1375-1380.
18. Rahal A, Peloquin L, Ahmarani C. Mitomycin C in sinus surgery: preliminary results in a rabbit model. J Otolaryngol 2001;30:1-5.
19. Hardillo J, Vanclooster C, Delaere PR. An investigation of airway wound healing using a novel in vivo model. Laryngoscope 2001;111:1174-1182.
20. Hartnick CJ, Hartley BE, Lacy PD, et al. Topical mitomycin application after laryngotracheal reconstruction: a randomized, double-blind, placebo-controlled trial. Arch Otolaryngol Head Neck Surg 2001;127:1260-1264.
21. Qiu JG, Factor S, Chang TH, Knighton D, Nadel H, Levenson SM. Wound healing: captopril, an angiogenesis inhibitor, and Staphylococcus aureus peptidoglycan. J Surg Res 2000;92:177-185.
22. Tabata Y, Miyao M, Yamamoto M, Ikada Y. Vascularization into a porous sponge by sustained release of basic fibroblast growth factor. J Biomater Sci Polym Ed 1999;10:957-968.
23. Bitar MS, Farook T, John B, Francis IM. Heat-shock protein 72/73 and impaired wound healing in diabetic and hypercortisolemic states. Surgery 1999;125:594-601.
24. Hu G, Tylzanowski P, Inoue H, Veis A. Relationship between translation of proál (I) and proá2 (I) mRNAs during synthesis of the type I procollagen heterotrimer. J Cell Biochem 1995;59-214-234.
25. Wells GMA, Catlin G, Crossings JA, et al. Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi-competitor cDNA standard. Glia 1996;18:332-340.
26. Mei H, Parks WC, Pierce RA. Developmental regulation of elastin production: expression of tropoelastin pre-mRNA persists after down-regulation of steady-state mRNA levels. J Biol Chem 1995;270:14899-14906.
27. Mohamadzadeh M, DeGrendele H, Arizpe H, Estess P, Siegelman M. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J Clin Invest 1998;101:97-108.
28. Ding H, Gray SD. Senescent expression of genes coding tropoelastin, elastase, lysyl oxidase, and tissue inhibitors of metalloproteinases in rat vocal folds: comparison with skin and lungs. J Speech Lang Hear Res 2001;44:317-326.
29. Ding H, Gray SD. Senescent expression of genes coding collagens, collagen-degrading metalloproteinases, and tissue inhibitors of metalloproteinases in rat vocal folds: comparison with skin and lungs. J Gerontol A Biol Sci Med Sci 2001;56:B145-152.
30. Sayani K, Dodd CM, Nedelec B, et al. Delayed appearance of decorin in healing burn scars. Histopathology 2000;36:262-272.
31. Boykiw R, Sciore P, Reno C, Marchuk L, Frank CB, Hart DA. Altered levels of extracellular matrix molecule mRNA in healing rabbit ligaments. Matrix Biol 1998;17:371-378.
32. Caron RM, Hamilton JW. Preferential effects of the chemotherapeutic DNA crosslinking agent mitomycin C on inducible gene expression in vivo. Environ Mol Mutagen 1995;25:4-11.
33. Caron RM, Ihnat MA, Hamilton JW. The promoter represents the critical target for the preferential effects of carcinogens on inducible gene expression, and chromatin structure is important for these effects. Proc Am Assoc Cancer Res 1994;35:142.
34. Caron RM, Hamilton JW. Developmentally specific effects of mitomycin C on PEPCK gene expression and correlation with chromatin structure. Proc Am Assoc Cancer Res 1995;36:158.
35. Garrett CG, Soto J, Riddick J, Billante CR, Reinisch L. Effect of mitomycin-C on vocal fold healing in a canine model. Ann Otol Rhinol Laryngol 2001;110:25-30.